US equities
|
SPCX
$166.68
▲+4.85%
NVDA
$236.66
▲+1.16%
MU
$1,064.05
▼-1.01%
TSLA
$377.85
▲+1.96%
MSFT
$525.60
▲+1.56%
SNDK
$1,710.74
▼-0.54%
INTC
$117.15
▼-1.83%
META
$745.61
▲+2.41%
SPCX
$166.68
▲+4.85%
NVDA
$236.66
▲+1.16%
MU
$1,064.05
▼-1.01%
TSLA
$377.85
▲+1.96%
MSFT
$525.60
▲+1.56%
SNDK
$1,710.74
▼-0.54%
INTC
$117.15
▼-1.83%
META
$745.61
▲+2.41%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Pieris Pharmaceuticals, Inc. - Common Stock
(NQ:
PIRS
)
13.60
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pieris Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Stocks Stunted Midday as Reopening Plays Weaken
↗
May 25, 2021
The major indexes have pared most of their pre-market gains, giving way to a somewhat static afternoon.
Via
Talk Markets
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 25, 2021
Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 43.23% to $2.65 during Tuesday's regular session. As of 12:30 EST, Pieris Pharmaceuticals's...
Via
Benzinga
What's Going On With Pieris Pharmaceuticals Stock Today?
↗
May 25, 2021
Pieris Pharmaceuticals Inc (NASDAQ:PIRS) shares are tradin...
Via
Benzinga
Pieris Stock Surges on Development Pact with Genentech for Respiratory, Ophthalmology Settings
↗
May 25, 2021
Pieris Pharmaceuticals Inc (NASDAQ: PIRS) has entered into a multi-program research collaboration and license agreement with Genentech, a unit of ...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 25, 2021
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) shares increased by 27.99% to $5.99 during Tuesday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech
May 25, 2021
- Pieris will receive $20 million as an upfront payment and is eligible to receive more than $1.4 billion in additional potential milestone payments plus royalties for commercialized programs -...
From
Pieris Pharmaceuticals, Inc.
Via
AccessWire
Pieris Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference
May 20, 2021
BOSTON, MA / ACCESSWIRE / May 20, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...
From
Pieris Pharmaceuticals, Inc.
Via
AccessWire
Pieris Pharmaceuticals: Q1 Earnings Insights
↗
May 17, 2021
Shares of Pieris Pharmaceuticals (NASDAQ:PIRS) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share increased 0.00% over the past...
Via
Benzinga
Pieris Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 17, 2021
COMPANY TO HOST AN INVESTOR CONFERENCE CALL ON MONDAY, MAY 17, 2021 AT 8:00 AM EDT - PRS-060/AZD1402 dosed to first patient in phase 2a study - Cinrebafusp alfa (PRS-343) phase 2 study expected to...
From
Pieris Pharmaceuticals, Inc.
Via
AccessWire
Earnings Scheduled For May 17, 2021
↗
May 17, 2021
Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter. • U.S. Well Services (NASDAQ:...
Via
Benzinga
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
↗
May 15, 2021
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back...
Via
Talk Markets
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
↗
May 15, 2021
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the...
Via
Benzinga
Earnings Preview: Pieris Pharmaceuticals
↗
May 14, 2021
On Monday, May 17, Pieris Pharmaceuticals (NASDAQ:PIRS) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release...
Via
Benzinga
Pieris Pharmaceuticals to Host First Quarter 2021 Investor Call and Provide Corporate Update on May 17, 2021
May 10, 2021
BOSTON, MA / ACCESSWIRE / May 10, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...
From
Pieris Pharmaceuticals, Inc.
Via
AccessWire
Topics
Regulatory Compliance
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
↗
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
April 26, 2021
- Pieris will receive $10 million upfront and be entitled to receive additional milestone payments and tiered royalties - Boston Pharmaceuticals will be primarily responsible for development of the...
From
Pieris Pharmaceuticals, Inc.
Via
AccessWire
Topics
Regulatory Compliance
55 Biggest Movers From Yesterday
↗
April 13, 2021
Gainers Celcuity Inc. (NASDAQ: CELC) jumped 29.4% to settle at $27.94. Celcuity shares climbed 51% on Friday after the company announced a worldwide licensing agreement with...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 12, 2021
Gainers 180 Life Sciences (NASDAQ:ATNF) shares increased by 27.31% to $12.4 during Monday's regular session. Trading volume for 180 Life Sciences's stock is 29.3...
Via
Benzinga
42 Stocks Moving In Monday's Mid-Day Session
↗
April 12, 2021
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the company's 13D filing showed that Modell's Sporting Goods had reported a stake...
Via
Benzinga
Pieris Pharmaceuticals Presents Updated Phase 1 Monotherapy Data for 4-1BB/HER2 Bispecific Cinrebafusp Alfa and Preclinical Data for 4-1BB/PD-L1 Bispecific PRS-344/S095012 at 2021 AACR Annual Meeting
April 10, 2021
- Additional, ongoing confirmed durable partial response and three additional patients with stable disease as best response at the highest dose cohort of cinrebafusp alfa - Durable anti-tumor activity...
From
Pieris Pharmaceuticals, Inc.
Via
AccessWire
Topics
Regulatory Compliance
< Previous
1
2
3
4
5
6
Next >
